The healthcare industry is seeing a major shift in diabetes therapy with the arrival of GLP-1 skin applications. These revolutionary delivery systems offer a likely convenient option to subcutaneous injections for individuals managing diabetes mellitus type 2. By bypassing the requirement for fre